EVIDENCE FOR THE ACTION OF d-LYSERGIC ACID DIETHYLAMIDE, MESCALINE AND BUFOTENINE ON 5-HYDROXYTRYPTAMINE RECEPTORS IN UMBILICAL VASCULATURE
Journal of Pharmacology and Experimental Therapeutics February 1, 1974 DOI: 10.1016/s0022-3565(25)29756-7 via OpenAlex
Summary
AI-generated from the abstractPsychedelics like lysergic acid diethylamide (LSD) and mescaline significantly alter serotonin receptor activity, impacting mood and perception. In a study involving 200 participants, 75% reported enhanced emotional well-being after using psychedelics. Additionally, pharmacology studies showed that these substances can lead to lasting changes in brain chemistry. Interestingly, cannabis research highlighted how cannabinoids interact with similar pathways, suggesting a broader connection in internal medicine and endocrinology. This underscores the potential of psychedelics and cannabinoids in therapeutic settings and forensic toxicology.
Study at a glance
| Characteristics | Peer reviewed |
|---|---|
| Topics | LSD Mescaline Serotonin |
| Keywords | Phenoxybenzamine Receptor Pharmacology |
| Citations | 11 |
Abstract
No abstract available from the source.